BARCELONA, Spain, April 6, 2020 /PRNewswire/ -- Grifols, S.A.
("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS) announced that
it has filed its 2019 Annual Report on Form 20-F with the United
States Securities and Exchange Commission ("SEC") on April 6, 2020. Grifols' Annual Report on Form
20-F includes its audited financial statements for its fiscal year
ended December 31, 2019.
Form 20-F can be accessed electronically through the Grifols
website at http://www.grifols.com/en/investors.The Form 20-F is
also available on the SEC's website at http://www.sec.gov.
Grifols will deliver, within a reasonable time after request, a
hard copy of the Form 20-F, including its complete audited
financial statements, free of charge, to any shareholder upon
request. To request a hard copy, shareholders may contact Grifols
by email at investors@grifols.com to the attention of Grifols'
Investor Relations, Re: 2019 Annual Report on Form 20-F.
About Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the
health and well-being of people around the world. Its four
divisions – Bioscience, Diagnostic, Hospital and Bio Supplies –
develop, produce and market innovative solutions and services that
are sold in more than 100 countries.
Pioneers in the plasma industry, Grifols operates a growing
network of donation centers worldwide. It transforms collected
plasma into essential medicines to treat rare, chronic and, at
times, life-threatening conditions. As a recognized leader in
transfusion medicine, Grifols also offers a comprehensive portfolio
of solutions designed to enhance safety from donation to
transfusion. In addition, the company supplies tools, information
and services that enable hospitals, pharmacies and healthcare
professionals to efficiently deliver expert medical care.
Grifols, with more than 24,000 employees in 30 countries, is
committed to a sustainable business model that sets the standard
for continuous innovation, quality, safety and ethical
leadership.
The company's class A shares are listed on the Spanish Stock
Exchange, where they are part of the Ibex35 (MCE:GRF). Grifols
non-voting class B shares are listed on the Mercado Continuo
(MCE:GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:GRFS).
For more information: www.grifols.com
View original
content:http://www.prnewswire.com/news-releases/grifols-2019-annual-report-on-form-20-f-filed-with-the-sec-on-april-6-2020-301035774.html
SOURCE Grifols, S.A.